Spectrum Pharmaceuticals Announces Authorization of Stock Repurchase Program up to $25M

Spectrum Pharmaceuticals, Inc. SPPI today announced that its Board of Directors has authorized the purchase of up to $25 million of its common stock through the end of 2012. Stock will be purchased from time to time, in the open market, through block trades, through 10b5-1 plans, or through privately negotiated transactions in compliance with Securities and Exchange Commission guidelines. The Company expects the stock repurchase program to help partially offset potential dilution from outstanding warrants and equity incentive programs.